Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the 2023 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Thursday, September 7^th. Ashley McEvoy, EVP, Worldwide Chairman, MedTech along with executives from Abiomed will represent the Company in a session scheduled at 10:15 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230807587886/en/

Investor Contact:

RA-JJCUS-InvestorRel@ITS.JNJ.com

Media Contact:

media-relations@its.jnj.com

Source: Johnson & Johnson